Evidence map›Paper›PMID 33908006›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Mapping O-glycosylation Sites Using OpeRATOR and LC-MS.

Maria Nordgren, Andreas Nägeli, Helén Nyhlén, Jonathan Sjögren

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maria NordgrenGenovis AB, Lund, Sweden.
Andreas NägeliGenovis AB, Lund, Sweden.
Helén NyhlénGenovis AB, Lund, Sweden.
Jonathan SjögrenGenovis AB, Lund, Sweden. jonathan.sjogren@genovis.com.
Genovis (Sweden) · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

O-glycosylation is a difficult posttranslational modification to analyze. O-glycans are labile and often cluster making their analysis by LC-MS very challenging. OpeRATOR is an O-glycan specific protease that cleaves the protein backbone N-terminally of glycosylated serine and threonine residues. This enables the generation of glycopeptides of suitable size for mapping O-glycosylation sites in detail by bottom-up LC-MS analysis. In this chapter we demonstrate a simple workflow for in-depth analysis of O-glycosylation sites on heavily glycosylated proteins using OpeRATOR digestion and HILIC-MS/MS analysis.

Indexed as

Chromatography, LiquidPeptide MappingProtein Processing, Post-TranslationalSpectrometry, Mass, Electrospray IonizationTandem Mass SpectrometryComplement C1 Inhibitor ProteinGlycosylationPeptide HydrolasesProteolysisResearch DesignWorkflowComplement C1 Inhibitor ProteinPeptide HydrolasesSERPING1 protein, humanGlycopeptidesGlycoproteomicsLC-MSMass spectrometryO-glycan specific proteaseO-glycosylationOpeRATOR

Identifiers

PMID33908006
OpenAlexW3157263164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.